Poor Studies Targeted Under New NIH Data Sharing Policy

Clinical trials could yield more useful results following a new NIH policy compelling researchers to devise plans for managing and sharing their data, the agency’s science policy chief said.

The U.S. clinical trials enterprise has faced heavy criticism for failing to yield groundbreaking results during the pandemic and producing trials that are mostly too small and poorly designed to do anything with those study results.

The final data sharing policy the National Institutes of Health released Thursday won’t fix the problem by itself. But Carrie D. Wolinetz, NIH acting chief of staff and associate director for science policy, said the ...